Early myocardial oedema can predict subsequent cardiomyopathy in high‐dose anthracycline therapy

AIMS: This study aims to assess subclinical changes in functional and morphologic myocardial MR parameters very early into a repetitive high‐dose anthracycline treatment (planned cumulative dose >650 mg/m(2)), which may predict subsequent development of anthracycline‐induced cardiomyopathy (aCMP)...

Descripción completa

Detalles Bibliográficos
Autores principales: Muehlberg, Fabian, Kornfeld, Markus, Zange, Leonora, Ghani, Saeed, Reichardt, Annette, Reichardt, Peter, Schulz‐Menger, Jeanette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871709/
https://www.ncbi.nlm.nih.gov/pubmed/36404640
http://dx.doi.org/10.1002/ehf2.14232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871709/
https://www.ncbi.nlm.nih.gov/pubmed/36404640
http://dx.doi.org/10.1002/ehf2.14232

Ejemplares similares